Stockrabit · Analysts
Questions across 2 calls

Amit Kadam

Canara Robeco

Mankind Pharma Limited

Mankind Pharma Limited CC-Mar24.pdf · 2024-05-16
So my question is, again, in the extension of what Alankar asked. Again, on that particular capital allocation strategy, because this is something which we are really curious about to know. The question is on the payback side. So assuming because we don't know the kind of acquisition you desire to do because there is no outer limit. But also, you mentioned about the debt-to-EBITDA kind of thing, Prakash just mentioned. But just wanted to understand, based on your previous acquisitions, small and large, whatever, what was the payback periods you usually target from such kind of acquisition? That's the only question from my end.
Yes. So basically, that number, we are not right now callin g out, that's a fair assumption? Or should...

C.E. Info Systems Limited

C.E. Info Systems Limited CC-Sep23.pdf · 2023-11-01
Again the question is on the C& E, your comments on that particular thing, what is C&E, but like just wanted to check is there a competition in this particular segment? Like with whom you compete and how the business comes to you? It is like a case-basis this particular thing you do it for a customer just can you elaborate. The whole point I wanted to just check, how the business comes to you and then like, do we have to compete for this particular business, because if that growth fluctuates quarterly, is it just the underlying market dynamics is only leading to that rather than any competition adjustments.
So, what I can get from this particular thing is that whenever our customer want a full bouquet or kind of thing then we are the only choice in the current times. But only like case-to-case basis or some if you break it down in that particular the value chain in smaller part then there will be some competition for each part.